STOCK TITAN

Andrew Wolfe sells 5,193 TBCH shares for $67.6K (NASDAQ: TBCH)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Andrew Wolfe reported a sale of 5,193 shares of Common Stock on 06/03/2026 under a Form 144 submission. The filing shows cash proceeds of $67,606.11. The report also lists prior restricted stock grants dated 04/01/2024 (4,088 shares) and 04/01/2025 (6,988 shares).

Positive

  • None.

Negative

  • None.

Insights

Routine issuer-share disposition by an individual filing Form 144; transaction appears administrative.

The filing records a reported disposition of 5,193 shares by Andrew Wolfe on 06/03/2026 for $67,606.11. The entry is a standard Form 144 disclosure required when restricted or control securities are sold and does not itself state the method of sale or any 10b5-1 plan.

Referenced restricted stock grants of 4,088 (04/01/2024) and 6,988 (04/01/2025) are listed; the filing does not tie those grants directly to the sale proceeds or state remaining holdings. Cash-flow treatment and timing beyond the sale date are not detailed in the excerpt.

Shares sold 5,193 shares Sale date <date>06/03/2026</date>
Proceeds $67,606.11 Proceeds from sale on <date>06/03/2026</date>
Restricted stock grant 4,088 shares Grant date <date>04/01/2024</date>
Restricted stock grant 6,988 shares Grant date <date>04/01/2025</date>
Form 144 regulatory
"144: Securities Sold During The Past 3 Months"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Restricted Stock financial
"Common | 04/01/2024 | Restricted Stock"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Issuer regulatory
"Restricted Stock | Issuer"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Andrew Wolfe report in the Form 144 for TBCH?

Andrew Wolfe reported selling 5,193 shares of Common Stock on 06/03/2026. The filing lists proceeds of $67,606.11 and references prior restricted stock grants from 04/01/2024 and 04/01/2025.

How much cash was reported from the sale in TBCH's Form 144?

The Form 144 shows cash proceeds of $67,606.11 from the reported sale. The filing does not specify how the sale was executed or whether proceeds were paid to the issuer or a third party.

Does the Form 144 show holdings or remaining shares for Andrew Wolfe?

The excerpt lists prior restricted grants of 4,088 shares (04/01/2024) and 6,988 shares (04/01/2025). It does not state Wolfe's post-transaction holdings or aggregate beneficial ownership in the provided text.

Are the referenced restricted stock grants part of the reported sale?

The filing lists restricted stock grants on 04/01/2024 and 04/01/2025. The excerpt does not explicitly connect those specific grants to the 6/3/2026 sale or state whether sold shares were derived from those awards.